Clinical Trials Logo

Clinical Trial Summary

Atrial myopathy is considered to be the underlying cause of a large proportion of embolic strokes of undetermined source. However, the definition of this atrial condition is not well delineated while its identification could lead to prescription on anticoagulation in order to avoid stroke recurences. This study aims to identify new markers of atrial myopathy and choosed a multi parametric approach with electrical, echographical, biological and 4D flow CMR derived markers.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04717843
Study type Interventional
Source Hospices Civils de Lyon
Contact Philippe CHEVALIER, Pr
Phone 4.72.35.70.27
Email philippe.chevalier@chu-lyon.fr
Status Recruiting
Phase N/A
Start date March 1, 2021
Completion date September 1, 2024

See also
  Status Clinical Trial Phase
Completed NCT04455529 - Current Situation of Natural History, Diagnosis and Treatment in Inpatients With Embolism Stroke of Unknown Cause (ESUS)
Completed NCT04604015 - RoBotic TCD Ultrasound BubbLe Study Compared to Transthoracic Echocardiography for Detection of Right to Left Shunt N/A
Completed NCT03107637 - Transesophageal Echocardiography in Embolic Stroke of Undetermined Source
Recruiting NCT04808258 - Embolic Stroke of Undetermined Source, Continuous Electrocardiography and Transthoracic ECHOcardiography in Hospitalized Patients With Ischemic Stroke
Completed NCT03712865 - Thirty Day Heart Monitoring for Detection of Atrial Fibrillation Among Cryptogenic Stroke Patients
Completed NCT03377465 - Biomarkers, Hemodynamic and Echocardiographic Predictors of Ischemic Strokes and Their Influence on the Course and Prognosis N/A
Recruiting NCT05431972 - Cardea SOLOTM for Paroxysmal Atrial Fibrillation Diagnosis in ESUS Patients With Left Atrial Enlargement N/A
Active, not recruiting NCT03329365 - Paroxysmal Nocturnal Hemoglobinuria in ESUS & ETUS
Recruiting NCT05089435 - An Open-label Study of EZYPRO® in Atrial Fibrillation Detection on ESUS Patients Phase 4
Enrolling by invitation NCT02766205 - Prediction of AF in ESUS
Recruiting NCT05238610 - Prospective Registry of Elderly ESUS With PFO
Recruiting NCT04898361 - PFO Occlusion and Atrial Fibrillation N/A
Recruiting NCT06100718 - Discovery of New Cancer in the 1-year Follow-up After Ischemic Stroke in Patients at Risk: The INVISIBLE-1 Study
Recruiting NCT05044208 - Echocardiographic Predictors of Atrial Fibrillation
Recruiting NCT03820375 - Registry Study for the Observation of Patients With ESUS/Cryptogenic Stroke
Completed NCT03609437 - Impaired Endothelial Integrity in Patients With Embolic Stroke of Undetermined Source (ESUS)
Completed NCT03185520 - Young ESUS Patient Registry
Completed NCT02427126 - Apixaban for Treatment of Embolic Stroke of Undetermined Source Phase 3